Skip to main content
Clinical Trials/ACTRN12624001151527
ACTRN12624001151527Not yet recruitingPhase 4

Effects of antibiotic prophylaxis on rates of early implant failure in dental implant surgery for adult patients: Randomized controlled clinical trial.

Master in Oral Surgery and Implantology, University of Granada0 sites100 target enrollmentStarted: September 23, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
100
Primary Endpoint
Early implant failure[Defined by removal of the implant before prosthetic loading. <br>Patient clinic review at 7 days, 14 days, 30 days and 90 days. If early implant failure occurs outside of these periods, the patient will go to the faculty's operating room. Baseline, 7 days, 14 days, 30 days, 90 days<br>]

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to No limit (—)
Sex
All

Inclusion Criteria

  • Patients 18 years and over• Subjects treated periodontally, if necessary, prior to placementof implants• Presence of sufficient bone and soft tissue that does not imply augmentation surgery in the moment of implant placement• Implants placed in a single surgical field

Exclusion Criteria

  • Patients who, due to their medical condition, require antibiotic prophylaxispostoperative (risk of endocarditis)• Patients undergoing head and neck radiotherapy less than 2 years ago• Diabetics (controlled and uncontrolled)• Allergic to penicillin• Patients treated with antiresorptive drugs• Pregnant or breastfeeding• Immunocompromised• Patients who are taking antibiotics for other reasons• Implants that require simultaneous bone regeneration• Implants in which immediate loading is carried out• Immediate implants

Outcomes

Primary Outcomes

Early implant failure[Defined by removal of the implant before prosthetic loading. <br>Patient clinic review at 7 days, 14 days, 30 days and 90 days. If early implant failure occurs outside of these periods, the patient will go to the faculty's operating room. Baseline, 7 days, 14 days, 30 days, 90 days<br>]

Secondary Outcomes

  • Presence of postoperatory infection [Postoperative pain and inflammation were evaluated daily on days 1 to 7 post-surgery using a VAS (0= no pain/swelling to 10=maximum imaginable pain/swelling), also recording the amount of anti-inflammatory/analgesic rescue medication taken each day. Presence of infection in the next control appointment (14 days, 30 days, 90 days). Baseline, days 1-7, 14 days, 30 days, 90 days post-surgery. ];Implant stability quotient (ISQ) values for primary and secondary implant stability[ISQ measured on the surgery day, and in day 90. baseline (surgery day) and 90 days post-surgery]

Investigators

Sponsor
Master in Oral Surgery and Implantology, University of Granada

Similar Trials